statistiche ricercatore

SPANEVELLO, ANTONIO

Distribuzione geografica

Continente	#
NA - Nord America	18.975
EU - Europa	9.747
AS - Asia	5.892
SA - Sud America	924
AF - Africa	91
OC - Oceania	45
Continente sconosciuto - Info sul continente non disponibili	12
Totale	35.686

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	18.814
IT - Italia	4.883
SG - Singapore	2.015
UA - Ucraina	1.552
CN - Cina	1.264
HK - Hong Kong	830
BR - Brasile	790
VN - Vietnam	738
TR - Turchia	681
SE - Svezia	647
IE - Irlanda	549
GB - Regno Unito	548
DE - Germania	422
FI - Finlandia	403
RU - Federazione Russa	295
NL - Olanda	101
CA - Canada	85
FR - Francia	84
IN - India	78
AT - Austria	72
MX - Messico	61
AR - Argentina	53
JP - Giappone	49
BD - Bangladesh	47
PL - Polonia	37
AU - Australia	32
BE - Belgio	26
ZA - Sudafrica	23
CZ - Repubblica Ceca	21
EC - Ecuador	21
ES - Italia	21
ID - Indonesia	21
KR - Corea	20
MA - Marocco	20
IQ - Iraq	18
CH - Svizzera	16
PK - Pakistan	16
SA - Arabia Saudita	14
TW - Taiwan	13
CL - Cile	12
NZ - Nuova Zelanda	12
PE - Perù	12
CO - Colombia	11
EU - Europa	11
MY - Malesia	11
UZ - Uzbekistan	10
DZ - Algeria	9
LT - Lituania	9
RO - Romania	9
VE - Venezuela	9
AE - Emirati Arabi Uniti	8
KZ - Kazakistan	8
EG - Egitto	7
IR - Iran	7
JO - Giordania	7
KE - Kenya	7
AL - Albania	6
BO - Bolivia	6
GR - Grecia	6
NO - Norvegia	6
PY - Paraguay	6
TN - Tunisia	6
DK - Danimarca	5
NG - Nigeria	5
OM - Oman	5
TH - Thailandia	5
BG - Bulgaria	4
HU - Ungheria	4
LK - Sri Lanka	4
MD - Moldavia	4
PT - Portogallo	4
BA - Bosnia-Erzegovina	3
CI - Costa d'Avorio	3
CR - Costa Rica	3
IL - Israele	3
MM - Myanmar	3
PA - Panama	3
SN - Senegal	3
UY - Uruguay	3
AZ - Azerbaigian	2
BB - Barbados	2
BH - Bahrain	2
GD - Grenada	2
GE - Georgia	2
GN - Guinea	2
HN - Honduras	2
HR - Croazia	2
KH - Cambogia	2
LU - Lussemburgo	2
LY - Libia	2
SK - Slovacchia (Repubblica Slovacca)	2
BY - Bielorussia	1
CY - Cipro	1
DO - Repubblica Dominicana	1
ET - Etiopia	1
GF - Guiana Francese	1
GH - Ghana	1
GT - Guatemala	1
JM - Giamaica	1
KG - Kirghizistan	1
Totale	35.672

Salva come PNG Salva come JPEG

Città	#
Milan	3.398
Fairfield	2.338
Woodbridge	1.831
Ashburn	1.466
Jacksonville	1.257
Houston	1.211
Ann Arbor	1.207
Chandler	1.100
Singapore	1.099
Wilmington	928
Seattle	926
Hong Kong	823
Cambridge	788
Dallas	544
Princeton	532
Dublin	531
Shenzhen	438
Dearborn	410
Boardman	380
Izmir	372
Nyköping	314
Dong Ket	285
Rome	271
Beijing	207
Chicago	203
The Dalles	184
New York	177
San Diego	168
London	151
Como	126
Los Angeles	123
San Mateo	120
Ogden	104
São Paulo	87
Hefei	75
Council Bluffs	70
Munich	70
Santa Clara	68
Helsinki	66
Washington	65
Ho Chi Minh City	58
Falls Church	57
Kocaeli	49
Nanjing	44
Tokyo	42
Hanoi	40
Nuremberg	40
Vienna	40
Kunming	39
Salt Lake City	37
San Francisco	37
Norwalk	36
Mexico City	34
Phoenix	34
Toronto	34
Rio de Janeiro	32
San Genesio Ed Uniti	32
Amsterdam	31
San Jose	31
Brooklyn	30
Warsaw	30
Verona	29
Guangzhou	28
Atlanta	27
Chennai	26
Columbus	26
Montreal	25
Brussels	24
Düsseldorf	23
Jinan	23
Redmond	23
Orem	22
Redwood City	22
Tampa	22
Shanghai	21
Buffalo	20
Belo Horizonte	19
Stockholm	19
Magnago	18
Kilburn	17
Philadelphia	17
Brno	16
Dhaka	16
Nanchang	16
Shenyang	16
Pavia	15
Indiana	14
Manchester	14
Turku	14
Ankara	13
Boston	13
Chiswick	13
New Bedfont	13
Zhengzhou	13
Chengdu	12
Fayetteville	12
Frankfurt am Main	12
Johannesburg	12
Porto Alegre	12
Prescot	12
Totale	26.029

Salva come PNG Salva come JPEG

Nome	#
Convergent sets of data from in vivo and in vitro methods point to an active role of Hsp60 in chronic obstructive pulmonary disease pathogenesis	573
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases	306
The effects of a cognitive behavioural intervention in asthmatic patients.	262
Airway inflammation in patients affected by obstructive sleep apnea	257
Classifying new anti-tuberculosis drugs: rationale and future perspectives	225
Five-year survival of stage IIIA-IIIB (non-N3) non-small cell lung cancer patients after platinum/gemcitabine induction chemotherapy and surgery.	222
Six-Minute Walking Distance Improvement after Pulmonary Rehabilitation Is Associated with Baseline Lung Function in Complex COPD Patients: A Retrospective Study	217
A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis	211
Adherence to Continuous Positive Airway Pressure in patients with Obstructive Sleep Apnoea. A ten year real life study	211
A European Respiratory Society technical standard: exhaled biomarkers in lung disease	209
Aging and airway inflammation	204
Airway inflammatory phenotypes: Making sputum cell evaluation more accessible for clinical use	199
Exhaled pH, exhaled nitric oxide, and induced sputum cellularity in obese patients with obstructive sleep apnea syndrome	197
Models of respiratory infections: Virus-induced asthma exacerbations and beyond	197
Clinical and operational value of the extensively drug-resistant tuberculosis definition.	196
3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer.	196
Therapeutic drug monitoring: How to improve drug dosage and patient safety in tuberculosis treatment	194
A pilot study of nurse-led, home monitoring for patients with chronic respiratory failure and with mechanical ventilation assistance.	192
Prognostic value of Exhaled Microsatellite alterations at 3p in NSCLC patients.	189
Aging and induced-sputum cells.	189
A new Editorial Board of Monaldi Archives for Chest Disease	187
Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey	183
Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae	183
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases.	182
Bronchoalveolar lavage causes decrease in PaO2, increase in (A-a) gradient value and bronchoconstriction in asthmatics.	182
History of tuberculosis and drug resistance	181
When kidneys and lungs suffer together	181
Improving the TB case management: The International Standards for Tuberculosis Care.	179
Tuberculosis elimination: theory and practice in Europe	179
Exhaled NO and iNOS expression in sputum cells of healthy, obese and OSA subjects	179
Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation.	178
Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.	178
Economic analysis of two structured treatment and teaching programs on asthma.	177
Microsatellite alterations suggestive of organ-specific asthma and atopy in exhaled breath condensate.	177
In vitro susceptibility testing and totally drug-resistant tuberculosis	177
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial	177
Efficacy of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): The Maugeri Study.	176
Ripped from the headlines: how can we harness communications to control TB?	176
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials	176
Brittle Asthma	174
Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance.	173
Induced sputum to assess airway inflammation: a study of reproducibility.	172
Bronchial hyperresponsiveness, airway inflammation, and reversibility in patients with chronic obstructive pulmonary disease	171
Effectiveness and safety of meropenem/ clavulanate-containing regimens in the treatment of MDR- and XDR-TB	170
Estimation of minimal clinically important difference in EQ-5D visual analog scale score after pulmonary rehabilitation in subjects with COPD	170
Exhaled matrix metalloproteinase-9 (MMP-9) in different biological phenotypes of asthma	170
Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease.	169
Markers of airway inflammation in pulmonary diseases assessed by induced sputum.	169
Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults.	168
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.	168
Prevalence and prevention of venous thromboembolism in patients with acute exacerbations of COPD	167
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells	167
Airway inflammation in patients affected by obstructive sleep apnea syndrome.	167
Airway responsiveness to methacholine: effects of deep inhalations and airway inflammation.	166
Effects of intradermal injection of atrial natriuretic peptide.	166
Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance.	166
Validity and reproducibility of morphologic analysis of nasal secretions obtained using ultrasonic nebulization of hypertonic solution.	166
Comparison of two methods of processing induced sputum: selected versus entire sputum.	164
Menopausal asthma: a new biological phenotype?	164
Airway inflammation in healthy smokers.	164
Comparison of effectiveness and safety of imipenem/clavulanate-versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB	164
Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity.	163
Heterogeneity of pulmonary rehabilitation: like apples and oranges - both healthy fruit	162
Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?	161
Recent developments in the diagnosis and management of tuberculosis	161
Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8.	160
European union standards for tuberculosis care.	160
Italian survey on prevalence and disease management of chronic heart failure and chronic obstructive pulmonary disease comorbidity in ambulatory patients. SUSPIRIUM study rationale and design	160
An electronic nose in the discrimination of patients with asthma and controls.	159
Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients	159
Epidemiology and clinical management of XDR-TB: a systematic review by TBNET.	158
Tele-assistance in Chronic Respiratory Failure Patients: a Randomised Clinical Trial.	157
Effect of methacholine challenge on cellular composition of sputum induction.	156
Latex allergy and sensitization in cities: a survey in a population at risk	156
Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease.	156
Exhaled inflammatory markers in aspirin-induced asthma syndrome.	156
Chronic bronchial asthma from challenge to treatment: epidemiology and social impact.	155
Efficacy and safety of surgical lung biopsy for interstitial disease. Experience of 161 consecutive patients from a single institution in Italy	155
Towards a practical clinical use of fractioned exhaled nitric oxide levels in chronic cough	155
Consensus not yet reached on key drugs for extensively drug-resistant tuberculosis treatment.	154
Sputum induced cellularity in a group of traffic policemen.	152
Effects of Pulmonary Rehabilitation in Patients with Non-Cystic Fibrosis Bronchiectasis: A Retrospective Analysis of Clinical and Functional Predictors of Efficacy	152
Is bronchodilator the correct treatment for COPD subjects before EBUS?	152
Assembly 5: Airway diseases	152
AIDS and tuberculosis control programmes: an integrated approach at educational level.	151
SPUTUM AND EXHALED BREATH ANALYSIS	151
Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma.	150
Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease	150
Management of drug resistantTB in patients with HIV co-infection	150
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.	149
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: A non-inferiority, randomised, double-blind clinical trial	149
Tuberculosis elimination: Where are we now?	149
Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD	148
The new frontiers of rehabilitation medicine in people with chronic disabling illnesses	148
Integrated care of chronic degenerative non-communicable diseases and rehabilitation: the odd couple?	148
Effectiveness of pulmonary rehabilitation in severe asthma: a retrospective data analysis	148
Airways diseases: asthma, COPD and chronic cough highlights from the European Respiratory Society Annual Congress 2018	147
The role of the bronchial microvasculature in the airway remodelling in asthma and COPD	146
Changes in sputum composition during 15 min of sputum induction in healthy subjects and patients with asthma and chronic obstructive pulmonary disease.	145
Attenuation of induced bronchoconstriction in healthy subjects: effects of breathing depth.	145
Totale	17.734

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	166.206
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	166.206

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	3.011	0	0	0	0	0	413	196	373	635	283	418	693
2021/2022	2.742	315	328	168	70	83	185	204	176	157	486	221	349
2022/2023	3.395	441	147	291	360	225	701	39	366	452	148	121	104
2023/2024	6.222	840	865	1.323	1.037	1.175	404	101	117	185	94	51	30
2024/2025	4.451	53	93	781	151	180	355	163	271	523	447	319	1.115
2025/2026	4.097	539	566	685	1.167	703	437	0	0	0	0	0	0
Totale													36.350